NRG1 is a critical regulator of differentiation in TP63-driven squamous cell carcinoma
Squamous cell carcinomas (SCCs) account for the majority of cancer mortalities. Although TP63 is an established lineage-survival oncogene in SCCs, therapeutic strategies have not been developed to target TP63 or it’s downstream effectors. In this study we demonstrate that TP63 directly regulates NRG...
Main Authors: | Ganapati V Hegde, Cecile de la Cruz, Jennifer M Giltnane, Lisa Crocker, Avinashnarayan Venkatanarayan, Gabriele Schaefer, Debra Dunlap, Joerg D Hoeck, Robert Piskol, Florian Gnad, Zora Modrusan, Frederic J de Sauvage, Christian W Siebel, Erica L Jackson |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2019-05-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/46551 |
Similar Items
-
Peripheral Transcription of NRG-ErbB Pathway Genes Are Upregulated in Treatment-Resistant Schizophrenia
by: Md Shaki Mostaid, et al.
Published: (2017-11-01) -
The Expression of Hippocampal NRG1/ErbB4 Correlates With Neuronal Apoptosis, but Not With Glial Activation During Chronic Cerebral Hypoperfusion
by: Yue Hei, et al.
Published: (2018-05-01) -
Identification of Novel CDH1-NRG2α and F11R-NRG2α Fusions in NSCLC Plus Additional Novel NRG2α Fusions in Other Solid Tumors by Whole Transcriptome Sequencing
by: Sai-Hong Ignatius Ou, MD, PhD, et al.
Published: (2021-02-01) -
NRG1 fusions in breast cancer
by: Karen D. Howarth, et al.
Published: (2021-01-01) -
Conditional activation of NRG1 signaling in the brain modulates cortical circuitry
by: Unterbarnscheidt, Tilmann
Published: (2015)